Takeda Pharmaceutical Co Ltd 2026 Integrated Report
Company: Takeda Pharmaceutical Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2026
Type: Integrated Report
Pages: 55
The report highlights Takeda's FY2025 progress across its pipeline, financial performance and sustainability agenda. It reports USD 28.3B in revenue, a 58% reduction in Scope 1 and 2 GHG emissions from the FY2016 baseline, and a 10% reduction in Scope 3 emissions from the FY2022 baseline. The company is pursuing net-zero emissions across its value chain by FY2040, with near-term reduction targets of 65% for Scope 1 and 2 and 25% for Scope 3 by FY2030.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.